All Global Research articles can be read in 51 languages by activating the “Translate Website” drop down menu on the top banner of our home page (Desktop version).
Visit and follow us on Instagram at @crg_globalresearch.
***
The Chief Epidemiologist of Iceland has decided that the Moderna vaccine against Covid-19 will not be used in Iceland. More information is needed on the safety of the vaccine for booster vaccinations and therefore not only people younger than 30 will be excluded, but everyone.
An announcement by the state concluded that in recent days there has been data from other Nordic countries on the increased incidence of myocarditis and pericarditis after vaccination with the Moderna vaccine in addition to the Pfizer/BioNTech vaccine.
According to the epidemiologist, the Moderna vaccine had for the past two months been used almost exclusively in Iceland for booster vaccinations after the Janssen vaccine and after two-dose vaccinations for the elderly and immunocompromised. Very few individuals are said to have received the second dose of Moderna.
In Sweden, the use of Moderna has been restricted to individuals born before 1991. In Norway and Denmark, it has been emphasized that the Pfizer vaccine is recommended rather than Moderna for 12 to 17 year olds.
In Iceland, only the Pfizer vaccine has been recommended for primary vaccination at 12 to 17 years of age since the vaccination of this particular age group began.
According to the Chief Epidemiologist, the decision was made to suspend the use of Moderna as there is a sufficient supply of the Pfizer vaccine for defined priority groups and basic vaccinations of those who have not yet been vaccinated.
*
Note to readers: Please click the share buttons above or below. Follow us on Instagram, @crg_globalresearch. Forward this article to your email lists. Crosspost on your blog site, internet forums. etc.
Featured image is from Pixabay
